Emerging Nanotechnology for Treatment of Alzheimer’s and Parkinson’s Disease

The prevalence of the two most common neurodegenerative diseases, Parkinson’s disease (PD) and Alzheimer’s Disease (AD), are expected to rise alongside the progressive aging of society. Both PD and AD are classified as proteinopathies with misfolded proteins α-synuclein, amyloid-β, and tau. Emerging...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Amanda, Tyson, Joel, Patel, Shivni, Patel, Meer, Katakam, Sruthi, Mao, Xiaobo, He, Weiwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Bioengineering and Biotechnology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8185219/
https://www.ncbi.nlm.nih.gov/pubmed/34113606
http://dx.doi.org/10.3389/fbioe.2021.672594

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8185219/
https://www.ncbi.nlm.nih.gov/pubmed/34113606
http://dx.doi.org/10.3389/fbioe.2021.672594

Ejemplares similares